-
1
-
-
0030866233
-
Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis
-
Sleat, DE, Donnelly, RJ, Lackland, H, Liu, CG, Sohar, I, Pullarkat, RK et al. (1997). Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 277: 1802-1805.
-
(1997)
Science
, vol.277
, pp. 1802-1805
-
-
Sleat, D.E.1
Donnelly, R.J.2
Lackland, H.3
Liu, C.G.4
Sohar, I.5
Pullarkat, R.K.6
-
2
-
-
0026539541
-
Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease)
-
Palmer, DN, Fearnley, IM, Walker, JE, Hall, NA, Lake, BD, Wolfe, LS et al. (1992). Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Med Genet 42: 561-567.
-
(1992)
Am J Med Genet
, vol.42
, pp. 561-567
-
-
Palmer, D.N.1
Fearnley, I.M.2
Walker, J.E.3
Hall, N.A.4
Lake, B.D.5
Wolfe, L.S.6
-
3
-
-
77956060447
-
The birth prevalence of lysosomal storage disorders in the Czech Republic: Comparison with data in different populations
-
Poupetová, H, Ledvinová, J, Berná, L, Dvoráková, L, Kozich, V and Elleder, M (2010). The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J Inherit Metab Dis 33: 387-396.
-
(2010)
J Inherit Metab Dis
, vol.33
, pp. 387-396
-
-
Poupetová, H.1
Ledvinová, J.2
Berná, L.3
Dvoráková, L.4
Kozich, V.5
Elleder, M.6
-
4
-
-
84873037158
-
Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy
-
Santorelli, FM, Garavaglia, B, Cardona, F, Nardocci, N, Bernardina, BD, Sartori, S et al. (2013). Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy. Orphanet J Rare Dis 8: 19.
-
(2013)
Orphanet J Rare Dis
, vol.8
, pp. 19
-
-
Santorelli, F.M.1
Garavaglia, B.2
Cardona, F.3
Nardocci, N.4
Bernardina, B.D.5
Sartori, S.6
-
5
-
-
84872479464
-
Enzyme replacement therapy for lysosomal diseases: Lessons from 20 years of experience and remaining challenges
-
Desnick, RJ and Schuchman, EH (2012). Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges. Annu Rev Genomics Hum Genet 13: 307-335.
-
(2012)
Annu Rev Genomics Hum Genet
, vol.13
, pp. 307-335
-
-
Desnick, R.J.1
Schuchman, E.H.2
-
6
-
-
32944476769
-
Enzyme replacement for lysosomal diseases
-
Brady, RO (2006). Enzyme replacement for lysosomal diseases. Annu Rev Med 57: 283-296.
-
(2006)
Annu Rev Med
, vol.57
, pp. 283-296
-
-
Brady, R.O.1
-
7
-
-
84877318308
-
The final frontier - Crossing the blood-brain barrier
-
Sly, WS and Vogler, C (2013). The final frontier - crossing the blood-brain barrier. EMBO Mol Med 5: 655-657.
-
(2013)
EMBO Mol Med
, vol.5
, pp. 655-657
-
-
Sly, W.S.1
Vogler, C.2
-
8
-
-
77649219162
-
Novel treatments and future perspectives: Outcomes of intrathecal drug delivery
-
Dickson, PI (2009). Novel treatments and future perspectives: outcomes of intrathecal drug delivery. Int J Clin Pharmacol Ther 47(suppl. 1): S124-S127.
-
(2009)
Int J Clin Pharmacol Ther
, vol.47
, Issue.SUPPL. 1
-
-
Dickson, P.I.1
-
9
-
-
77649195183
-
Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases
-
Hemsley, KM and Hopwood, JJ (2009). Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases. Int J Clin Pharmacol Ther 47(suppl. 1): S118-S123.
-
(2009)
Int J Clin Pharmacol Ther
, vol.47
, Issue.SUPPL. 1
-
-
Hemsley, K.M.1
Hopwood, J.J.2
-
10
-
-
82455208854
-
Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis
-
Vuillemenot, BR, Katz, ML, Coates, JR, Kennedy, D, Tiger, P, Kanazono, S et al. (2011). Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis. Mol Genet Metab 104: 325-337.
-
(2011)
Mol Genet Metab
, vol.104
, pp. 325-337
-
-
Vuillemenot, B.R.1
Katz, M.L.2
Coates, J.R.3
Kennedy, D.4
Tiger, P.5
Kanazono, S.6
-
11
-
-
80053568718
-
Large-volume intrathecal enzyme delivery increases survival of a mouse model of late infantile neuronal ceroid lipofuscinosis
-
Xu, S, Wang, L, El-Banna, M, Sohar, I, Sleat, DE and Lobel, P (2011). Large-volume intrathecal enzyme delivery increases survival of a mouse model of late infantile neuronal ceroid lipofuscinosis. Mol Ther 19: 1842-1848.
-
(2011)
Mol Ther
, vol.19
, pp. 1842-1848
-
-
Xu, S.1
Wang, L.2
El-Banna, M.3
Sohar, I.4
Sleat, D.E.5
Lobel, P.6
-
12
-
-
41149092265
-
Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis
-
Chang, M, Cooper, JD, Sleat, DE, Cheng, SH, Dodge, JC, Passini, MA et al. (2008). Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis. Mol Ther 16: 649-656.
-
(2008)
Mol Ther
, vol.16
, pp. 649-656
-
-
Chang, M.1
Cooper, J.D.2
Sleat, D.E.3
Cheng, S.H.4
Dodge, J.C.5
Passini, M.A.6
-
13
-
-
84855597543
-
Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier
-
Pardridge, WM and Boado, RJ (2012). Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier. Meth Enzymol 503: 269-292.
-
(2012)
Meth Enzymol
, vol.503
, pp. 269-292
-
-
Pardridge, W.M.1
Boado, R.J.2
-
14
-
-
79958024590
-
Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIA
-
Rozaklis, T, Beard, H, Hassiotis, S, Garcia, AR, Tonini, M, Luck, A et al. (2011). Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIA. Exp Neurol 230: 123-130.
-
(2011)
Exp Neurol
, vol.230
, pp. 123-130
-
-
Rozaklis, T.1
Beard, H.2
Hassiotis, S.3
Garcia, A.R.4
Tonini, M.5
Luck, A.6
-
15
-
-
0019788642
-
Delivery of hexosaminidase A to the cerebrum after osmotic modification of the blood-brain barrier
-
Neuwelt, EA, Barranger, JA, Brady, RO, Pagel, M, Furbish, FS, Quirk, JM et al. (1981). Delivery of hexosaminidase A to the cerebrum after osmotic modification of the blood-brain barrier. Proc Natl Acad Sci USA 78: 5838-5841.
-
(1981)
Proc Natl Acad Sci USA
, vol.78
, pp. 5838-5841
-
-
Neuwelt, E.A.1
Barranger, J.A.2
Brady, R.O.3
Pagel, M.4
Furbish, F.S.5
Quirk, J.M.6
-
16
-
-
84877596293
-
A highly secreted sulphamidase engineered to cross the blood-brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA
-
Sorrentino, NC, D'Orsi, L, Sambri, I, Nusco, E, Monaco, C, Spampanato, C et al. (2013). A highly secreted sulphamidase engineered to cross the blood-brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA. EMBO Mol Med 5: 675-690.
-
(2013)
EMBO Mol Med
, vol.5
, pp. 675-690
-
-
Sorrentino, N.C.1
D'Orsi, L.2
Sambri, I.3
Nusco, E.4
Monaco, C.5
Spampanato, C.6
-
17
-
-
84874271571
-
Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier
-
Wang, D, El-Amouri, SS, Dai, M, Kuan, CY, Hui, DY, Brady, RO et al. (2013). Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier. Proc Natl Acad Sci USA 110: 2999-3004.
-
(2013)
Proc Natl Acad Sci USA
, vol.110
, pp. 2999-3004
-
-
Wang, D.1
El-Amouri, S.S.2
Dai, M.3
Kuan, C.Y.4
Hui, D.Y.5
Brady, R.O.6
-
18
-
-
40649102937
-
Chemically modified beta-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII
-
Grubb, JH, Vogler, C, Levy, B, Galvin, N, Tan, Y and Sly, WS (2008). Chemically modified beta-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII. Proc Natl Acad Sci USA 105: 2616-2621.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 2616-2621
-
-
Grubb, J.H.1
Vogler, C.2
Levy, B.3
Galvin, N.4
Tan, Y.5
Sly, W.S.6
-
19
-
-
84867653884
-
Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII
-
Huynh, HT, Grubb, JH, Vogler, C and Sly, WS (2012). Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII. Proc Natl Acad Sci USA 109: 17022-17027.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, pp. 17022-17027
-
-
Huynh, H.T.1
Grubb, J.H.2
Vogler, C.3
Sly, W.S.4
-
20
-
-
26844534412
-
Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII
-
Vogler, C, Levy, B, Grubb, JH, Galvin, N, Tan, Y, Kakkis, E et al. (2005). Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII. Proc Natl Acad Sci USA 102: 14777-14782.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 14777-14782
-
-
Vogler, C.1
Levy, B.2
Grubb, J.H.3
Galvin, N.4
Tan, Y.5
Kakkis, E.6
-
21
-
-
84863692409
-
Systemic administration of tripeptidyl peptidase i in a mouse model of late infantile neuronal ceroid lipofuscinosis: Effect of glycan modification
-
Meng, Y, Sohar, I, Wang, L, Sleat, DE and Lobel, P (2012). Systemic administration of tripeptidyl peptidase I in a mouse model of late infantile neuronal ceroid lipofuscinosis: effect of glycan modification. PLoS ONE 7: e40509.
-
(2012)
PLoS ONE
, vol.7
-
-
Meng, Y.1
Sohar, I.2
Wang, L.3
Sleat, D.E.4
Lobel, P.5
-
22
-
-
5744254381
-
Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: A preclinical animal study
-
Roces, DP, Lüllmann-Rauch, R, Peng, J, Balducci, C, Andersson, C, Tollersrud, O et al. (2004). Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal study. Hum Mol Genet 13: 1979-1988.
-
(2004)
Hum Mol Genet
, vol.13
, pp. 1979-1988
-
-
Roces, D.P.1
Lüllmann-Rauch, R.2
Peng, J.3
Balducci, C.4
Andersson, C.5
Tollersrud, O.6
-
23
-
-
78649483570
-
Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy
-
Polito, VA, Abbondante, S, Polishchuk, RS, Nusco, E, Salvia, R and Cosma, MP (2010). Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy. Hum Mol Genet 19: 4871-4885.
-
(2010)
Hum Mol Genet
, vol.19
, pp. 4871-4885
-
-
Polito, V.A.1
Abbondante, S.2
Polishchuk, R.S.3
Nusco, E.4
Salvia, R.5
Cosma, M.P.6
-
24
-
-
83755206474
-
A carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brain
-
Sarkar, G, Curran, GL, Mahlum, E, Decklever, T, Wengenack, TM, Blahnik, A et al. (2011). A carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brain. PLoS ONE 6: e28881.
-
(2011)
PLoS ONE
, vol.6
-
-
Sarkar, G.1
Curran, G.L.2
Mahlum, E.3
Decklever, T.4
Wengenack, T.M.5
Blahnik, A.6
-
25
-
-
0023220763
-
Intracarotid infusions of protamine sulfate disrupt the bloodbrain barrier of rabbits
-
Strausbaugh, LJ (1987). Intracarotid infusions of protamine sulfate disrupt the bloodbrain barrier of rabbits. Brain Res 409: 221-226.
-
(1987)
Brain Res
, vol.409
, pp. 221-226
-
-
Strausbaugh, L.J.1
-
26
-
-
0027430683
-
Protamine-mediated transport of albumin into brain and other organs of the rat. Binding and endocytosis of protamine-albumin complex by microvascular endothelium
-
Pardridge, WM, Buciak, JL, Kang, YS and Boado, RJ (1993). Protamine-mediated transport of albumin into brain and other organs of the rat. Binding and endocytosis of protamine-albumin complex by microvascular endothelium. J Clin Invest 92: 2224-2229.
-
(1993)
J Clin Invest
, vol.92
, pp. 2224-2229
-
-
Pardridge, W.M.1
Buciak, J.L.2
Kang, Y.S.3
Boado, R.J.4
-
27
-
-
34247872806
-
Engineering a noncarrier to a highly efficient carrier peptide for noncovalently delivering biologically active proteins into human cells
-
Mahlum, E, Mandal, D, Halder, C, Maran, A, Yaszemski, MJ, Jenkins, RB et al. (2007). Engineering a noncarrier to a highly efficient carrier peptide for noncovalently delivering biologically active proteins into human cells. Anal Biochem 365: 215-221.
-
(2007)
Anal Biochem
, vol.365
, pp. 215-221
-
-
Mahlum, E.1
Mandal, D.2
Halder, C.3
Maran, A.4
Yaszemski, M.J.5
Jenkins, R.B.6
-
28
-
-
5644241723
-
A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase i activity and progressive neurodegeneration
-
Sleat, DE, Wiseman, JA, El-Banna, M, Kim, KH, Mao, Q, Price, S et al. (2004). A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration. J Neurosci 24: 9117-9126.
-
(2004)
J Neurosci
, vol.24
, pp. 9117-9126
-
-
Sleat, D.E.1
Wiseman, J.A.2
El-Banna, M.3
Kim, K.H.4
Mao, Q.5
Price, S.6
-
29
-
-
0033910620
-
Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: Comparison of tripeptidyl peptidase i and pepstatininsensitive protease assays
-
Sohar, I, Lin, L and Lobel, P (2000). Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: comparison of tripeptidyl peptidase I and pepstatininsensitive protease assays. Clin Chem 46: 1005-1008.
-
(2000)
Clin Chem
, vol.46
, pp. 1005-1008
-
-
Sohar, I.1
Lin, L.2
Lobel, P.3
-
30
-
-
63649139250
-
Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis
-
Guhaniyogi, J, Sohar, I, Das, K, Stock, AM and Lobel, P (2009). Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis. J Biol Chem 284: 3985-3997.
-
(2009)
J Biol Chem
, vol.284
, pp. 3985-3997
-
-
Guhaniyogi, J.1
Sohar, I.2
Das, K.3
Stock, A.M.4
Lobel, P.5
-
31
-
-
34548759601
-
Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease
-
Cabrera-Salazar, MA, Roskelley, EM, Bu, J, Hodges, BL, Yew, N, Dodge, JC et al. (2007). Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease. Mol Ther 15: 1782-1788.
-
(2007)
Mol Ther
, vol.15
, pp. 1782-1788
-
-
Cabrera-Salazar, M.A.1
Roskelley, E.M.2
Bu, J.3
Hodges, B.L.4
Yew, N.5
Dodge, J.C.6
-
32
-
-
0035397487
-
Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis
-
Lin, L and Lobel, P (2001). Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis. Biochem J 357(Pt 1): 49-55.
-
(2001)
Biochem J
, vol.357
, Issue.PART 1
, pp. 49-55
-
-
Lin, L.1
Lobel, P.2
-
33
-
-
84867232376
-
Effects of synthetic cathinones contained in "bath salts" on motor behavior and a functional observational battery in mice
-
Marusich, JA, Grant, KR, Blough, BE and Wiley, JL (2012). Effects of synthetic cathinones contained in "bath salts" on motor behavior and a functional observational battery in mice. Neurotoxicology 33: 1305-1313.
-
(2012)
Neurotoxicology
, vol.33
, pp. 1305-1313
-
-
Marusich, J.A.1
Grant, K.R.2
Blough, B.E.3
Wiley, J.L.4
-
34
-
-
0037196246
-
A simple method to measure stride length as an index of nigrostriatal dysfunction in mice
-
Fernagut, PO, Diguet, E, Labattu, B and Tison, F (2002). A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. J Neurosci Methods 113: 123-130.
-
(2002)
J Neurosci Methods
, vol.113
, pp. 123-130
-
-
Fernagut, P.O.1
Diguet, E.2
Labattu, B.3
Tison, F.4
|